Capricor Therapeutics Current Ratio 2010-2025 | CAPR

Capricor Therapeutics current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Capricor Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-03-31 $0.15B $0.02B 6.55
2024-12-31 $0.16B $0.02B 7.77
2024-09-30 $0.09B $0.02B 4.19
2024-06-30 $0.03B $0.02B 1.37
2024-03-31 $0.04B $0.03B 1.57
2023-12-31 $0.05B $0.03B 1.63
2023-09-30 $0.03B $0.03B 0.90
2023-06-30 $0.04B $0.04B 1.11
2023-03-31 $0.05B $0.04B 1.26
2022-12-31 $0.04B $0.02B 1.82
2022-09-30 $0.05B $0.02B 2.05
2022-06-30 $0.05B $0.02B 2.69
2022-03-31 $0.06B $0.01B 4.16
2021-12-31 $0.04B $0.00B 8.82
2021-09-30 $0.04B $0.00B 13.82
2021-06-30 $0.04B $0.00B 12.20
2021-03-31 $0.04B $0.00B 11.36
2020-12-31 $0.03B $0.00B 11.33
2020-09-30 $0.04B $0.00B 15.58
2020-06-30 $0.04B $0.00B 19.06
2020-03-31 $0.01B $0.00B 10.39
2019-12-31 $0.01B $0.00B 11.74
2019-09-30 $0.01B $0.00B 7.59
2019-06-30 $0.01B $0.00B 4.24
2019-03-31 $0.01B $0.00B 5.27
2018-12-31 $0.01B $0.00B 6.75
2018-09-30 $0.01B $0.00B 6.07
2018-06-30 $0.01B $0.00B 10.26
2018-03-31 $0.02B $0.00B 9.89
2017-12-31 $0.02B $0.00B 9.41
2017-09-30 $0.02B $0.02B 0.91
2017-06-30 $0.01B $0.02B 0.82
2017-03-31 $0.01B $0.00B 4.08
2016-12-31 $0.02B $0.01B 3.70
2016-09-30 $0.02B $0.01B 3.36
2016-06-30 $0.01B $0.01B 1.90
2016-03-31 $0.02B $0.01B 2.03
2015-12-31 $0.01B $0.01B 2.14
2015-09-30 $0.02B $0.01B 2.71
2015-06-30 $0.02B $0.01B 3.15
2015-03-31 $0.03B $0.01B 3.37
2014-12-31 $0.01B $0.01B 1.84
2014-09-30 $0.01B $0.01B 2.29
2014-06-30 $0.02B $0.01B 2.53
2014-03-31 $0.01B $0.01B 2.23
2013-12-31 $0.00B $0.00B 1.79
2013-09-30 $0.00B $0.00B 0.09
2013-06-30 $0.00B $0.00B 0.29
2013-03-31 $0.00B $0.00B 0.62
2012-12-31 $0.01B $0.00B 9.81
2012-09-30 $0.00B $0.00B 1.53
2012-06-30 $0.00B $0.00B 3.53
2012-03-31 $0.00B $0.00B 1.35
2011-12-31 $0.00B $0.00B 2.42
2011-09-30 $0.00B $0.00B 4.22
2011-06-30 $0.00B $0.00B 8.34
2011-03-31 $0.00B $0.00B 3.16
2010-12-31 $0.00B $0.00B 3.37
2010-09-30 $0.01B $0.00B 3.15
2010-06-30 $0.01B $0.00B 5.05
2010-03-31 $0.00B $0.00B 2.58
2009-12-31 $0.00B $0.00B 5.39
2009-09-30 $0.01B $0.00B 5.39
2009-06-30 $0.00B $0.00B 4.44
2009-03-31 $0.00B $0.00B 5.07
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.538B $0.022B
Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $235.957B 28.37
Boston Scientific (BSX) United States $147.560B 36.94
Stryker (SYK) United States $144.011B 30.11
EssilorLuxottica (ESLOY) France $127.141B 0.00
Medtronic (MDT) Ireland $111.928B 15.87
Lonza Group Ag (LZAGY) Switzerland $50.371B 0.00
Haleon (HLN) United Kingdom $48.926B 27.87
ResMed (RMD) United States $36.560B 27.46
Agilent Technologies (A) United States $33.258B 21.68
GE HealthCare Technologies (GEHC) United States $33.082B 15.71
Terumo (TRUMY) Japan $26.680B 34.65
Insulet (PODD) United States $21.438B 84.15
Koninklijke Philips (PHG) Netherlands $21.384B 15.37
Zimmer Biomet Holdings (ZBH) United States $18.060B 11.60
Baxter (BAX) United States $15.713B 11.73
Smith & Nephew SNATS (SNN) United Kingdom $12.872B 0.00
Demant (WILYY) Denmark $9.377B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Bio-Rad Laboratories (BIO) United States $6.175B 21.49
Lantheus Holdings (LNTH) United States $5.385B 13.58
Prestige Consumer Healthcare (PBH) United States $4.149B 18.54
Perrigo (PRGO) Ireland $3.664B 9.29
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.367B 15.34
ICU Medical (ICUI) United States $3.250B 23.96
Envista Holdings (NVST) United States $3.127B 25.99
QuidelOrtho (QDEL) United States $1.954B 13.44
LeMaitre Vascular (LMAT) United States $1.833B 40.97
AtriCure (ATRC) United States $1.565B 0.00
Acuren (TIC) United States $1.357B 0.00
Neogen (NEOG) United States $1.200B 15.36
AdaptHealth (AHCO) United States $1.161B 11.78
Green Thumb Industries (GTBIF) United States $1.048B 23.58
BioLife Solutions (BLFS) United States $1.046B 0.00
Phibro Animal Health (PAHC) United States $0.970B 12.40
Kestra Medical Technologies (KMTS) United States $0.904B 0.00
InMode (INMD) Israel $0.844B 8.51
Evolus (EOLS) United States $0.640B 0.00
CeriBell (CBLL) United States $0.624B 0.00
Owens & Minor (OMI) United States $0.602B 4.99
Maravai LifeSciences Holdings (MRVI) United States $0.542B 0.00
Curaleaf Holdings (CURLF) Canada $0.524B 0.00
Valneva SE (VALN) France $0.510B 0.00
Surmodics (SRDX) United States $0.417B 0.00
Tilray Brands (TLRY) Canada $0.407B 0.00
SNDL (SNDL) Canada $0.339B 0.00
VAREX IMAGING (VREX) United States $0.337B 12.41
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Aurora Cannabis (ACB) Canada $0.329B 58.50
Canopy Growth (CGC) Canada $0.272B 0.00
Viemed Healthcare (VMD) United States $0.263B 22.17
Sanara MedTech (SMTI) United States $0.256B 0.00
Sanuwave Health (SNWV) United States $0.254B 0.00
ZimVie (ZIMV) United States $0.253B 11.52
Cerus (CERS) United States $0.252B 0.00
Cresco Labs (CRLBF) United States $0.245B 0.00
Quanterix (QTRX) United States $0.235B 0.00
OraSure Technologies (OSUR) United States $0.221B 0.00
Biote (BTMD) United States $0.207B 5.82
Brainsway (BWAY) Israel $0.206B 54.50
Omeros (OMER) United States $0.199B 0.00
TriSalus Life Sciences (TLSI) United States $0.196B 0.00
Organigram Global (OGI) Canada $0.187B 0.00
High Tide (HITI) Canada $0.185B 0.00
Utah Medical Products (UTMD) United States $0.179B 14.59
Verano Holdings (VRNOF) United States $0.174B 0.00
Exagen (XGN) United States $0.152B 0.00
Vireo Growth (VREOF) United States $0.140B 0.00
FitLife Brands (FTLF) United States $0.131B 16.18
Jin Medical (ZJYL) China $0.107B 0.00
MacroGenics (MGNX) United States $0.096B 0.00
Fonar (FONR) United States $0.090B 11.64
Veru (VERU) United States $0.090B 0.00
Quipt Home Medical (QIPT) United States $0.087B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Agape ATP (ATPC) $0.084B 0.00
TerrAscend (TSNDF) Canada $0.075B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
InterCure (INCR) Israel $0.068B 0.00
Apyx Medical (APYX) United States $0.066B 0.00
Zynex (ZYXI) United States $0.064B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Modular Medical (MODD) United States $0.042B 0.00
Nephros (NEPH) United States $0.041B 55.29
United-Guardian (UG) United States $0.037B 12.90
Rockwell Medical (RMTI) United States $0.032B 0.00
Cellectar Biosciences (CLRB) United States $0.019B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
Safety Shot (SHOT) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.017B 0.00
INLIF (INLF) $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
Senestech (SNES) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00